Amyris Inc (STU:3A01)
€ 0.055 0 (0%) Market Cap: 692,000.00 Enterprise Value: 951.03 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Amyris Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 07:15PM GMT
Release Date Price: €1.36 (+0.64%)
Noah James Burhance
JPMorgan Chase & Co, Research Division - Research Analyst

It's my pleasure to introduce John and the Amyris team, and we'll do 20 minutes of presentation and then about 20 minutes of Q&A. So turning it over to you, John.

John G. Melo
Amyris, Inc. - President, CEO & Director

Great. Noah, thank you very much. I think I left some product in the back. So good morning to everyone. Great to have everybody here in the room and those listening on the outside, thank you. Appreciate that.

We are going to be making forward-looking statements. Here's a disclaimer regarding those statements. Again, we are Amyris. We are the science making our planet healthier. What that really means is we focus on using biotechnology to engineer microbes that take cheap sources of carbon and make high-value chemistry using fermentation. And we're the world leader in doing that as we'll share with you a little bit through our presentation.

We are remaking the world sustainable. Our real mission is we believe there's a way that most

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot